The Autoimmune Protocol and Rheumatoid Arthritis: What the Research Shows

What You’ll Learn in This Article:

• Insights from individuals with RA who have used AIP long term
• Findings from the first peer-reviewed AIP intervention trial in RA
• Changes in disease activity, pain, fatigue, and sleep during the intervention
• Participant experiences with food reintroduction and personalization
• What participants maintained one year after the study
• Implications for patient support and future research

Together, these studies provide the first scientific foundation for understanding how AIP may support individuals living with rheumatoid arthritis.

From Anecdote to Evidence

Long before research began, many individuals with RA turned to AIP in hopes of reducing symptoms that persisted despite medication. Across online communities and patient networks, AIP became a frequently discussed strategy for managing joint pain, inflammation, and fatigue. Reports of improved mobility, fewer flares, and better energy were common, but lacked scientific validation.

In recent years, that has begun to change. Early researchers sought to understand how patients were using AIP, what benefits and challenges they experienced, and whether AIP might offer a supportive role in RA management. The first study focused on the experiences of long-term AIP users, followed by a pilot clinical intervention and a longitudinal qualitative study examining implementation, reintroduction, and dietary changes one year later. Although these studies do not assess biomarkers or disease activity scores in depth, they offer valuable early evidence about AIP’s feasibility, safety, and potential symptom benefits.

RA remains one of the autoimmune conditions where patients most actively explore AIP, making this early research an important first step toward understanding how dietary and lifestyle changes may complement conventional treatment.

Study 1: Qualitative Research on Patient Experience (2020)

The first published study examining AIP for RA was conducted by nutritionist and PhD candidate Julianne McNeill in New Zealand (published under Taylor, 2020). Rather than measuring inflammatory markers, the study used qualitative interviews to explore how people with RA implemented AIP, what challenges they encountered, and what benefits they perceived. [1]

Study Design

The study explored the experiences of ten adults living with rheumatoid arthritis—nine women and one man—between the ages of 28 and 60. On average, participants had been following the Autoimmune Protocol for nearly three years, with individual experience ranging from six months to five years.

Rather than focusing on laboratory markers or standardized disease scores, researchers conducted in-depth, 90-minute semi-structured interviews to better understand each participant’s personal journey with AIP. Conversations centered on what initially motivated them to try the protocol, how they implemented it in everyday life, the challenges they encountered, the forms of support that helped them continue, and the changes they perceived over time.

Importantly, the study intentionally recruited individuals who felt they had benefited from AIP. The goal was not to determine whether AIP “worked” in a clinical sense, but to explore what successful, sustained implementation looked like from the patient perspective—and to identify the factors that may support long-term adherence.

Results

Several consistent themes emerged from the interviews. Most participants were first introduced to the Autoimmune Protocol through holistic practitioners or online autoimmune communities. For many, the decision to try AIP was driven by persistent pain, limited function, and a desire for options beyond conventional treatment alone. The hope of reducing daily discomfort and regaining a sense of control over their health served as a powerful motivator.

When it came to implementation, many described choosing a deliberate start date and transitioning relatively quickly into the elimination phase—particularly those experiencing more severe symptoms. While the structure of the protocol provided clarity, participants also acknowledged meaningful challenges. The restrictive nature of the elimination phase was frequently cited as difficult, and several described navigating skepticism, misunderstanding, or dismissive attitudes from friends, family members, or even healthcare providers.

Despite these barriers, nearly all participants emphasized the importance of support. Having at least one encouraging person—a partner, friend, or knowledgeable practitioner—was often described as critical to sustaining the protocol during challenging moments.

Ultimately, pain reduction emerged as the most significant factor in maintaining AIP long term. Participants commonly reported improvements substantial enough that the dietary restrictions felt justified. For many, the perceived benefits outweighed the difficulties, reinforcing their commitment to continuing the approach.

Discussion

This qualitative study provided the first structured exploration of how individuals with rheumatoid arthritis experience the Autoimmune Protocol in real life. Rather than measuring laboratory markers or standardized disease activity scores, the research centered on patient narratives—offering valuable insight into what motivates individuals to begin AIP, what helps them sustain it, and what obstacles they encounter along the way.

Although the study was not designed to evaluate clinical efficacy, participants consistently reported meaningful improvements in pain levels, energy, sleep quality, and overall daily functioning. For many, these changes were substantial enough to influence long-term adherence, even in the face of dietary restrictions and social challenges. These patient-reported outcomes suggest that AIP may influence dimensions of health that matter deeply to individuals living with RA, including quality of life and perceived control over symptoms.

The study also highlighted the importance of preparation, social support, and access to reliable information as key facilitators of success. At the same time, it underscored common barriers—such as the restrictive nature of elimination and social skepticism—that may limit broader adoption or sustainability without guidance.

Importantly, by documenting consistent patterns across participants, this research helped move the conversation beyond anecdote. It established a foundation for future quantitative and intervention-based studies by identifying both the potential benefits worth measuring and the practical considerations necessary for real-world implementation. In this way, the findings laid important groundwork for subsequent pilot trials designed to formally assess feasibility, symptom changes, and clinical outcomes in rheumatoid arthritis. [1]

Study 2: Rheumatoid Arthritis Pilot Feasibility Study (McNeill et al., 2026)

Building on earlier qualitative research exploring patient experiences with the Autoimmune Protocol (AIP), McNeill and colleagues published the first peer-reviewed clinical study evaluating AIP in adults with rheumatoid arthritis (RA). Published in Musculoskeletal Care in 2026, this pilot feasibility study examined whether AIP could be successfully implemented in a real-world setting and whether it was associated with changes in disease activity, symptom burden, and quality of life. [2]

Study Design

This single-arm pilot study was conducted in New Zealand and enrolled adults with a confirmed diagnosis of rheumatoid arthritis. Participants completed a 4-week control phase in which they continued their usual diet, followed by an 8-week Core AIP elimination phase. Throughout the intervention, participants received nutrition education, detailed implementation resources, ongoing support from a nutrition professional, and access to a private online support community. This approach was designed to reflect how AIP is often implemented in clinical practice.

Researchers collected weekly patient-reported outcome measures using two validated rheumatoid arthritis assessment tools:

• RAPID3 (Routine Assessment of Patient Index Data 3), which evaluates disease activity
• RAID (Rheumatoid Arthritis Impact of Disease), which assesses pain, fatigue, sleep, physical function, emotional wellbeing, and overall disease impact

Additional measures included dietary adherence, food intake, body weight, waist circumference, and participant feedback regarding the feasibility of following the protocol.

The study was conducted during the COVID-19 pandemic, requiring portions of data collection and participant support to be delivered remotely. Despite these challenges, adherence remained high throughout the intervention.

Results

The study found improvements across multiple patient-reported outcomes.

Seven of the nine participants experienced meaningful improvements in rheumatoid arthritis symptoms during the AIP intervention. Four participants achieved clinically significant reductions in disease activity scores, and three participants transitioned into remission-level disease activity by the end of the study.

Researchers also observed:

• Improvements in pain
• Reductions in fatigue
• Better sleep quality
• Improved overall disease impact scores
• Reduced use of discretionary anti-inflammatory medications among many participants
• High levels of dietary adherence and participant engagement

The greatest improvements were generally observed between weeks six and eight of the intervention. Researchers also reported reductions in body weight and waist circumference among most participants, although weight loss was not an intended outcome of the study.

Discussion

This study provides the strongest clinical evidence to date supporting the use of AIP as a complementary dietary approach for rheumatoid arthritis. While the study was small and did not include a randomized control group, it demonstrated that AIP can be implemented successfully in people with RA and may be associated with improvements in disease activity, pain, fatigue, sleep, and overall quality of life.

The findings are particularly notable because fatigue and sleep disturbances remain among the most common unmet needs in rheumatoid arthritis care, even among patients receiving standard medical treatment. Researchers concluded that larger controlled trials are warranted to further evaluate the effectiveness, mechanisms, and long-term sustainability of AIP in rheumatoid arthritis management. [2]

As with all current AIP research, these findings should be viewed as preliminary. However, the publication of this peer-reviewed intervention study marks an important milestone in the growing evidence base supporting dietary and lifestyle approaches as complementary tools in autoimmune disease management.

Study 3: Longitudinal Study of Participant Experience and Reintroduction (McNeill et al., 2026)

Following the 2026 pilot intervention, McNeill and colleagues conducted a longitudinal qualitative study examining how the same nine participants experienced AIP during the intervention and how their diets evolved after structured support ended. Participants were interviewed immediately after completing the eight-week AIP elimination phase and again one year later, allowing researchers to explore not only the initial challenges and benefits of AIP, but also food reintroduction, long-term sustainability, and the factors that helped participants maintain dietary changes [3].

Study Design

Researchers conducted individual semi-structured interviews with all nine participants at two time points: immediately following the AIP intervention and one year later. Interviews explored participants’ motivations for trying AIP, challenges and supports during the elimination phase, perceived changes in RA symptoms and general wellbeing, experiences with food reintroduction, and the dietary changes they maintained over time.

After completing the intervention, participants received instructions for staged food reintroductions but no further formal dietary support. This allowed researchers to examine how participants adapted AIP independently in everyday life once the structure and accountability of the clinical study were removed.

Results

During the intervention, participants described high motivation and adherence, with professional guidance, household support, peer connection, and practical resources helping them navigate the substantial dietary change. Common challenges included the time required for meal preparation, sourcing unfamiliar ingredients, social eating, and the mental burden of following a restrictive diet.

Seven of the nine participants perceived health improvements during the intervention, including reductions in joint pain, swelling, and stiffness, as well as improvements in energy, sleep, and digestive symptoms. Two participants did not experience these benefits and reported adverse or worsening symptoms.

At the one-year follow-up, most participants had moved away from strict AIP and developed a more flexible, personalized way of eating. The formal reintroduction process was generally considered difficult to sustain, but participants used their experiences with reintroduced foods to identify foods they perceived as triggering symptoms and foods they could tolerate.

Most also retained elements of AIP, including eating more nutrient-dense foods, increasing plant food variety, preparing more meals at home, and limiting foods associated with symptoms. Six participants reported that their RA symptoms remained stable or improved compared with before the intervention.

Discussion

This study provides an important longer-term perspective on AIP that cannot be captured by an eight-week clinical intervention alone. Participants generally did not view strict elimination as a sustainable permanent diet. Instead, most transitioned toward a more flexible, individualized approach while retaining dietary habits they found beneficial.

The findings also highlight the importance of support during implementation and greater guidance during reintroduction. Household involvement, professional guidance, peer support, practical preparation, and eventually greater dietary flexibility all contributed to adherence and sustainability.

Importantly, this was a qualitative study, and the authors emphasize that participants’ reports of symptom improvement should not be interpreted as evidence of clinical efficacy. Instead, the study provides valuable insight into the lived experience of AIP and suggests that elimination followed by personalization may result in meaningful, sustainable dietary changes for some people with RA [3].